Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Nov 23, 2022
- Accession no.
- 0001447362-22-000180
- Filed
- Nov 23, 2022
- Trade date
- Nov 21-22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $185.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock | SSaleDisposed | −2,869 | $20.84F2 | −$59,789.96 | 289,520 | Direct | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −1,403 | $20.84F2 | −$29,238.52 | 129,425 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −1,310 | $20.84F2 | −$27,300.4 | 117,914 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −279 | $20.84F2 | −$5,814.36 | 26,319 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −281 | $20.84F2 | −$5,856.04 | 26,316 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −281 | $20.84F2 | −$5,856.04 | 26,316 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −281 | $20.84F2 | −$5,856.04 | 26,312 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −964 | $20.51F9 | −$19,771.64 | 288,556 | Direct | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −472 | $20.51F9 | −$9,680.72 | 128,953 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −440 | $20.51F9 | −$9,024.4 | 117,474 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −96 | $20.51F9 | −$1,968.96 | 26,223 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −94 | $20.51F9 | −$1,927.94 | 26,222 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −94 | $20.51F9 | −$1,927.94 | 26,222 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −94 | $20.51F9 | −$1,927.94 | 26,218 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.50 to $21.08, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $20.32 to $20.67, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.